Flexion Therapeutics Net Profit Margin 2012-2019 | FLXN

Flexion Therapeutics net profit margin from 2012 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Flexion Therapeutics Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-09-30 $0.06B $-0.16B -261.67%
2019-06-30 $0.05B $-0.16B -362.22%
2019-03-31 $0.03B $-0.17B -534.38%
2018-12-31 $0.02B $-0.17B -743.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.627B $0.023B
Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. Flexion Therapeutics, Inc. is headquartered in Burlington, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $56.137B 33.58
Astellas Pharma (ALPMY) Japan $33.066B 15.76
Eisai (ESALY) Japan $19.882B 38.34
Merck (MKGAF) Germany $15.419B 21.04
Grifols, S.A (GRFS) Spain $14.796B 18.88
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.201B 481.61
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.999B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.026B 16.26
Sage Therapeutics (SAGE) United States $7.563B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.362B 9.40
Catalent (CTLT) United States $7.245B 29.48
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.320B 19.13
United Therapeutics (UTHR) United States $4.020B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.992B 91.52
FibroGen (FGEN) United States $3.617B 90.48
Nektar Therapeutics (NKTR) United States $3.513B 0.00
Evotec AG (EVTCY) Germany $3.183B 43.58
Taro Pharmaceutical Industries (TARO) Israel $2.962B 10.82
PTC Therapeutics (PTCT) United States $2.538B 0.00
Tilray (TLRY) Canada $2.287B 0.00
Portola Pharmaceuticals (PTLA) United States $2.214B 0.00
Zogenix (ZGNX) United States $1.920B 0.00
Xencor (XNCR) United States $1.887B 57.35
Pacira Pharmaceuticals (PCRX) United States $1.833B 54.35
Ironwood Pharmaceuticals (IRWD) United States $1.728B 55.10
Corcept Therapeutics (CORT) United States $1.715B 20.85
Heron Therapeutics (HRTX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.641B 17.51
Enanta Pharmaceuticals (ENTA) United States $1.250B 20.62
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.147B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.997B 0.00
Endo (ENDP) Ireland $0.982B 1.80
Spectrum Pharmaceuticals (SPPI) United States $0.973B 0.00
ArQule (ARQL) United States $0.925B 0.00
Karyopharm Therapeutics (KPTI) United States $0.924B 0.00
Aerie Pharmaceuticals (AERI) United States $0.891B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.817B 5.57
Dova Pharmaceuticals (DOVA) United States $0.806B 0.00
TherapeuticsMD (TXMD) United States $0.773B 0.00
Organogenesis Holdings (ORGO) United States $0.682B 0.00
Collegium Pharmaceutical (COLL) United States $0.669B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.563B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.522B 0.00
ImmunoGen (IMGN) United States $0.501B 0.00
Concordia (CXRXF) Canada $0.494B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Akebia Therapeutics (AKBA) United States $0.483B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.465B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Siga Technologies (SIGA) United States $0.450B 10.29
Dermira (DERM) United States $0.449B 0.00
OptiNose (OPTN) United States $0.414B 0.00
Recro Pharma (REPH) United States $0.391B 0.00
Indivior (INVVY) United States $0.387B 1.40
Rigel Pharmaceuticals (RIGL) United States $0.377B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.371B 16.03
Ardelyx (ARDX) United States $0.366B 0.00
DURECT (DRRX) United States $0.365B 0.00
Innate Pharma SA (IPHYF) France $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.19
Molecular Templates (MTEM) United States $0.338B 0.00
Harpoon Therapeutics (HARP) United States $0.320B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.297B 0.00
GlycoMimetics (GLYC) United States $0.271B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.265B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
KalVista Pharmaceuticals (KALV) United States $0.198B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.186B 0.00
Calithera Biosciences (CALA) United States $0.182B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.180B 31.07
MARKER THERAPEUTICS, INC (MRKR) United States $0.177B 0.00
CV Sciences (CVSI) United States $0.170B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Ocular Therapeutix (OCUL) United States $0.157B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.154B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Aquestive Therapeutics (AQST) United States $0.135B 0.00
Jounce Therapeutics (JNCE) United States $0.135B 1.80
MEI Pharma (MEIP) United States $0.135B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Cardiome Pharma (CORV) Canada $0.117B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
Majesco Entertainment (PTE) United States $0.089B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
Neos Therapeutics (NEOS) United States $0.085B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.081B 0.00
Generex Biotechnology (GNBT) United States $0.077B 0.00
Otonomy (OTIC) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Lipocine (LPCN) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.064B 9.67
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
IntelGenx Technologies (IGXT) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.054B 0.00
Nivalis Therapeutics (ALPN) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.048B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.035B 0.00
Mast Therapeutics (SVRA) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.032B 0.00
Melinta Therapeutics (MLNT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
PharmAthene (ALT) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00